235 related articles for article (PubMed ID: 30887707)
1. FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1.
Yang W; Feng B; Meng Y; Wang J; Geng B; Cui Q; Zhang H; Yang Y; Yang J
J Cell Mol Med; 2019 May; 23(5):3464-3475. PubMed ID: 30887707
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis.
Chen L; Yang Y; Peng X; Yan H; Zhang X; Yin L; Yu H
Aging (Albany NY); 2020 May; 12(9):8339-8351. PubMed ID: 32396525
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
4. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
Woosley AN; Dalton AC; Hussey GS; Howley BV; Mohanty BK; Grelet S; Dincman T; Bloos S; Olsen SK; Howe PH
Oncogene; 2019 May; 38(20):3794-3811. PubMed ID: 30692635
[TBL] [Abstract][Full Text] [Related]
5. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.
Wan M; Huang W; Kute TE; Miller LD; Zhang Q; Hatcher H; Wang J; Stovall DB; Russell GB; Cao PD; Deng Z; Wang W; Zhang Q; Lei M; Torti SV; Akman SA; Sui G
Am J Pathol; 2012 May; 180(5):2120-33. PubMed ID: 22440256
[TBL] [Abstract][Full Text] [Related]
6. ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.
He L; Lv S; Ma X; Jiang S; Zhou F; Zhang Y; Yu R; Zhao Y
Med Oncol; 2022 Jan; 39(4):45. PubMed ID: 35092510
[TBL] [Abstract][Full Text] [Related]
7. Characterization of YY1 OPB Peptide for its Anticancer Activity.
Qi Y; Yan T; Chen L; Zhang Q; Wang W; Han X; Li D; Shi J; Sui G
Curr Cancer Drug Targets; 2019; 19(6):504-511. PubMed ID: 30381079
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor YY1 mediates epithelial-mesenchymal transition through the TGFβ signaling pathway in bladder cancer.
Xia W; Li Y; Wu Z; Wang Y; Xing N; Yang W; Wu S
Med Oncol; 2020 Sep; 37(10):93. PubMed ID: 32970204
[TBL] [Abstract][Full Text] [Related]
9. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
10. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
11. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
[TBL] [Abstract][Full Text] [Related]
12. FAM3C activates HSF1 to suppress hepatic gluconeogenesis and attenuate hyperglycemia of type 1 diabetic mice.
Chen Z; Wang J; Yang W; Chen J; Meng Y; Feng B; Chi Y; Geng B; Zhou Y; Cui Q; Yang J
Oncotarget; 2017 Dec; 8(62):106038-106049. PubMed ID: 29285313
[TBL] [Abstract][Full Text] [Related]
13. YY1-Induced Transcriptional Activation of FAM111B Contributes to the Malignancy of Breast Cancer.
Li W; Hu S; Han Z; Jiang X
Clin Breast Cancer; 2022 Jun; 22(4):e417-e425. PubMed ID: 34802969
[TBL] [Abstract][Full Text] [Related]
14. FAM3C in Cancer-Associated Adipocytes Promotes Breast Cancer Cell Survival and Metastasis.
Kim S; Oh J; Park C; Kim M; Jo W; Kim CS; Cho SW; Park J
Cancer Res; 2024 Feb; 84(4):545-559. PubMed ID: 38117489
[TBL] [Abstract][Full Text] [Related]
15. The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.
Lieberthal JG; Kaminsky M; Parkhurst CN; Tanese N
Breast Cancer Res; 2009; 11(3):R42. PubMed ID: 19566924
[TBL] [Abstract][Full Text] [Related]
16. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
17. Heat shock factor 1 in cancer-associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma.
Wang Q; Zhang YC; Zhu LF; Pan L; Yu M; Shen WL; Li B; Zhang W; Liu LK
Cancer Sci; 2019 May; 110(5):1790-1803. PubMed ID: 30843645
[TBL] [Abstract][Full Text] [Related]
18. Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasis.
Kral M; Klimek C; Kutay B; Timelthaler G; Lendl T; Neuditschko B; Gerner C; Sibilia M; Csiszar A
FEBS J; 2017 Oct; 284(20):3484-3505. PubMed ID: 28837266
[TBL] [Abstract][Full Text] [Related]
19. NRF2 transcriptionally activates the
Paul S; Ghosh S; Mandal S; Sau S; Pal M
J Biol Chem; 2018 Dec; 293(50):19303-19316. PubMed ID: 30309986
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer.
Yang T; Ren C; Lu C; Qiao P; Han X; Wang L; Wang D; Lv S; Sun Y; Yu Z
Cancer Res; 2019 Oct; 79(20):5233-5244. PubMed ID: 31409638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
